Free Trial

MyHealthChecked (MHC) Competitors

MyHealthChecked logo
GBX 12.28 +0.53 (+4.47%)
As of 07:03 AM Eastern

MHC vs. POLX, IHC, AVO, RUA, SUN, BELL, DEMG, NIOX, SN, and MXCT

Should you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry.

MyHealthChecked vs. Its Competitors

MyHealthChecked (LON:MHC) and Polarean Imaging (LON:POLX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, community ranking, earnings and risk.

3.1% of MyHealthChecked shares are owned by institutional investors. Comparatively, 12.1% of Polarean Imaging shares are owned by institutional investors. 53.6% of MyHealthChecked shares are owned by company insiders. Comparatively, 39.3% of Polarean Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, MyHealthChecked had 1 more articles in the media than Polarean Imaging. MarketBeat recorded 1 mentions for MyHealthChecked and 0 mentions for Polarean Imaging. MyHealthChecked's average media sentiment score of 0.00 equaled Polarean Imaging'saverage media sentiment score.

Company Overall Sentiment
MyHealthChecked Neutral
Polarean Imaging Neutral

MyHealthChecked has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Polarean Imaging has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500.

MyHealthChecked has higher revenue and earnings than Polarean Imaging. MyHealthChecked is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MyHealthChecked£9.43M0.68-£1.04M-£2.00-6.12
Polarean Imaging£5.21M3.38-£69.44M-£3.89-0.31

Polarean Imaging received 23 more outperform votes than MyHealthChecked when rated by MarketBeat users.

CompanyUnderperformOutperform
MyHealthCheckedN/AN/A
Polarean ImagingOutperform Votes
23
67.65%
Underperform Votes
11
32.35%

MyHealthChecked has a net margin of -11.06% compared to Polarean Imaging's net margin of -1,333.97%. MyHealthChecked's return on equity of -12.80% beat Polarean Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
MyHealthChecked-11.06% -12.80% -8.18%
Polarean Imaging -1,333.97%-86.11%-32.28%

Summary

MyHealthChecked beats Polarean Imaging on 9 of the 13 factors compared between the two stocks.

Get MyHealthChecked News Delivered to You Automatically

Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MHC vs. The Competition

MetricMyHealthCheckedMedical Devices IndustryMedical SectorLON Exchange
Market Cap£6.39M£3.28B£5.61B£2.92B
Dividend YieldN/A2.44%5.28%4.90%
P/E Ratio-6.1272.5327.14123.68
Price / Sales0.68111.72414.30247,849.08
Price / Cash1.7815.9938.2528.07
Price / Book0.843.817.074.69
Net Income-£1.04M£126.02M£3.23B£5.91B
7 Day Performance8.87%-0.13%0.71%18.25%
1 Month Performance2.29%10.60%9.65%22.35%
1 Year Performance22.75%-4.57%32.07%77.85%

MyHealthChecked Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MHC
MyHealthChecked
N/AGBX 12.28
+4.5%
N/A+0.5%£6.39M£9.43M-6.1216Gap Down
POLX
Polarean Imaging
N/AGBX 1.37
-0.7%
N/A-19.7%£20.03M£5.21M-0.3528
IHC
Inspiration Healthcare Group
N/AGBX 21.98
+2.2%
N/A+20.0%£19.04M£42.87M-1.51224Positive News
Gap Up
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11.53
-1.9%
N/A+16.1%£7.16M£4.05M-2.6948
SUN
Surgical Innovations Group
N/AGBX 0.73
+4.0%
N/A+66.4%£6.79M£12.54M-21.1180
BELL
Belluscura
N/AGBX 0.79
-1.4%
N/A-92.5%£1.99M£2.87M-0.0824Gap Up
DEMG
Deltex Medical Group
N/AN/AN/AN/A£187K£1.76M-0.1537Gap Up
High Trading Volume
NIOX
NIOX Group
N/AGBX 71.40
-1.9%
GBX 90
+26.1%
-1.2%£29.33B£3.53B2,946.5592
SN
Smith & Nephew
4.0364 of 5 stars
GBX 1,082.50
+0.0%
GBX 7,840
+624.2%
+11.1%£11.87B£7.08B38.9718,452Positive News
High Trading Volume
MXCT
MaxCyte
N/AGBX 166.50
+0.6%
N/A-57.0%£219.79M£57.52M-6.1080News Coverage
Negative News
Gap Down

Related Companies and Tools


This page (LON:MHC) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners